Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The manufacturability of therapeutic monoclonal antibodies is limited by the harsh conditions that antibodies are subjected to during the purification procedure, which in turn restricts the development of novel acid-sensitive antibodies. |